Stocks
Health Care
ibrx
ImmunityBio
NASDAQ: IBRX
+1.58 (+39.87%)
5.525
USD
At close at Jan 16, 21:39 UTC
Income Statement
Revenue
14.74M
Gross Profit
14.74M
Operating Income
-344.18M
Pretax Income
-348.69M
Net Income
-413.56M
EBITDA
-235.93M
EBIT
-259.24M
Earnings Per Share
-0.5900000000000001
Balance Sheet
Cash & Cash Equivalents
129.63M
Total Debt
924.71M
Net Cash
-
Net Cash Per Share
-
Equity (Book Value)
-655.16M
Book Value Per Share
-0.95
Working Capital
-
Join our newsletter to keep up to date with us!
Cashu is the #1 way to stay ahead of the markets, know why your favourite stocks are moving and access valuation signals that smash the market.